Study of Curcumin, Vorinostat, and Sorafenib

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The goal of this clinical research study is to learn the highest tolerable dose of the combination of curcumin, vorinostat, and sorafenib that can be given to patients with advanced solid cancer. The safety of this drug combination will also be studied.
Epistemonikos ID: 4230d4d61202aa1d82eca023ab0dc3359e454457
First added on: May 11, 2024